Michael Maschan

3.0k total citations
152 papers, 1.4k citations indexed

About

Michael Maschan is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Michael Maschan has authored 152 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 53 papers in Oncology and 51 papers in Immunology. Recurrent topics in Michael Maschan's work include Hematopoietic Stem Cell Transplantation (45 papers), CAR-T cell therapy research (40 papers) and Acute Lymphoblastic Leukemia research (38 papers). Michael Maschan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), CAR-T cell therapy research (40 papers) and Acute Lymphoblastic Leukemia research (38 papers). Michael Maschan collaborates with scholars based in Russia, United States and Germany. Michael Maschan's co-authors include Dmitry Balashov, Галина Новичкова, Alexey Maschan, Alexei Maschan, Alexandra Laberko, Eva M. Weissinger, Reuven Or, Michael Schumm, Kathrin Opherk and Peter Lang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Maschan

116 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Maschan Russia 17 604 589 522 360 237 152 1.4k
Austen Worth United Kingdom 24 867 1.4× 403 0.7× 343 0.7× 353 1.0× 353 1.5× 56 1.8k
Goichi Yoshimoto Japan 20 831 1.4× 835 1.4× 476 0.9× 183 0.5× 614 2.6× 68 2.2k
Yoshiki Akatsuka Japan 31 1.9k 3.1× 902 1.5× 926 1.8× 353 1.0× 540 2.3× 111 2.8k
Alana A. Kennedy‐Nasser United States 13 757 1.3× 436 0.7× 1.3k 2.6× 396 1.1× 517 2.2× 23 2.1k
Kumi Oshima Japan 23 372 0.6× 775 1.3× 385 0.7× 440 1.2× 182 0.8× 70 1.5k
Martha Holladay United States 19 744 1.2× 382 0.6× 679 1.3× 262 0.7× 330 1.4× 21 1.4k
Il‐Kang Na Germany 22 594 1.0× 520 0.9× 437 0.8× 122 0.3× 374 1.6× 69 1.4k
Justyna Ogonek Germany 11 404 0.7× 263 0.4× 504 1.0× 146 0.4× 214 0.9× 14 945
Meagan A. Jacoby United States 18 197 0.3× 492 0.8× 539 1.0× 469 1.3× 453 1.9× 65 1.3k
Paulo Vidal Campregher Brazil 12 950 1.6× 429 0.7× 569 1.1× 140 0.4× 323 1.4× 57 1.7k

Countries citing papers authored by Michael Maschan

Since Specialization
Citations

This map shows the geographic impact of Michael Maschan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Maschan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Maschan more than expected).

Fields of papers citing papers by Michael Maschan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Maschan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Maschan. The network helps show where Michael Maschan may publish in the future.

Co-authorship network of co-authors of Michael Maschan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Maschan. A scholar is included among the top collaborators of Michael Maschan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Maschan. Michael Maschan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larin, Sergey S., et al.. (2025). Experience in developing and scaling a protocol for NK lymphocyte enriched cellular product manufacturing for clinical application. Pediatric Hematology/Oncology and Immunopathology. 24(2). 27–37.
2.
Pershin, Dmitry, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children. Transplantation and Cellular Therapy. 30(4). 437.e1–437.e11. 1 indexed citations
3.
4.
Larionova, Irina, et al.. (2023). Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases. npj Systems Biology and Applications. 9(1). 41–41. 3 indexed citations
5.
Kurnikova, Elena, et al.. (2023). The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience. Pediatric Hematology/Oncology and Immunopathology. 22(1). 62–72.
6.
Demina, I. A., et al.. (2023). Guidelines for the use of flow cell sorting in diagnosis and monitoring of acute leukemia. Pediatric Hematology/Oncology and Immunopathology. 22(4). 186–205. 1 indexed citations
7.
Maschan, Michael, et al.. (2023). Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy. Pediatric Hematology/Oncology and Immunopathology. 22(2). 175–184. 3 indexed citations
8.
Olshanskaya, Yulia, Michael Maschan, Yuri B. Lebedev, et al.. (2023). The use of non-functional clonotypes as a natural calibrator for quantitative bias correction in adaptive immune receptor repertoire profiling. eLife. 12. 6 indexed citations
9.
Evseev, D. A., et al.. (2023). Approaches to the treatment of a multisystem form of juvenile xanthogranuloma with central nervous system lesion. Russian Journal of Pediatric Hematology and Oncology. 10(1). 41–48.
10.
Попов, А. М., et al.. (2022). Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(2). 127.e1–127.e9. 6 indexed citations
11.
Kurnikova, Elena, et al.. (2022). The use of adoptive cell therapy for the treatment of SARS-CoV-2 in a patient after allogeneic hematopoietic stem cell transplantation. Pediatric Hematology/Oncology and Immunopathology. 21(2). 112–117.
12.
Pershin, Dmitry, et al.. (2022). Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study. Blood Advances. 6(19). 5582–5588. 4 indexed citations
13.
Balashov, Dmitry, et al.. (2021). Treosulfan-based conditioning for hematopoietic stem cell transplantation in patients with Diamond–Blackfan anemia. Pediatric Hematology/Oncology and Immunopathology. 20(1). 40–45.
14.
15.
Balashov, Dmitry, Alexandra Laberko, K. A. Voronin, et al.. (2020). EFFICACY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN ALTERNATIVE DONOR ON THE PLATFORM OF TRANSPLANT CELL MODELING TECHNOLOGY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES. PEDIATRIA Journal named after G N SPERANSKY. 99(2). 43–51. 2 indexed citations
16.
Pershin, Dmitry, et al.. (2020). Development of flow cytometry assay for Wiskott–Aldrich syndrome diagnosis by WASP protein evaluation. Pediatric Hematology/Oncology and Immunopathology. 19(2). 141–151. 1 indexed citations
17.
Pershin, Dmitry, et al.. (2020). Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method. Pediatric Hematology/Oncology and Immunopathology. 19(4). 108–118.
18.
Komkov, Alexander, А. М. Попов, Mikhail V. Pogorelyy, et al.. (2019). High‐throughput sequencing of T‐cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies. British Journal of Haematology. 188(5). 723–731. 9 indexed citations
19.
Shekhovtsova, Zhanna, et al.. (2018). The Influence of Natural Killer Cell Alloreactivity on the Outcome of α/βTCR/CD19+ depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Leukemia. Pediatric Hematology/Oncology and Immunopathology. 17(2). 39–50. 1 indexed citations
20.
Новичкова, Галина, et al.. (2014). Results of candidemia treatment in children with hematologic malignancies: single center experience. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Austen Worth Breakdown of academic impact, for papers by Goichi Yoshimoto Breakdown of academic impact, for papers by Yoshiki Akatsuka Breakdown of academic impact, for papers by Alana A. Kennedy‐Nasser Breakdown of academic impact, for papers by Kumi Oshima Breakdown of academic impact, for papers by Martha Holladay Breakdown of academic impact, for papers by Il‐Kang Na Breakdown of academic impact, for papers by Justyna Ogonek Breakdown of academic impact, for papers by Meagan A. Jacoby Breakdown of academic impact, for papers by Paulo Vidal Campregher
Rankless by CCL
2026